Summary & Overview
D&C, Conization, Laparoscopy and Tubal Interruption with CC/MCC: Inpatient Reimbursement Overview
DRG 744 includes inpatient admissions involving dilation and curettage, cervical conization, laparoscopy, and tubal interruption when a Major Complication or Comorbidity or Complication or Comorbidity is present, affecting resource intensity. This Diagnosis-Related Group is important for inpatient reimbursement because the presence of a Major Complication or Comorbidity or Complication or Comorbidity changes payment relative to less complex cases.
DRG 744 Overview
DRG 744 covers inpatient admissions for dilation and curettage, cervical conization, laparoscopy, and tubal interruption when a Major Complication or Comorbidity or Complication or Comorbidity is present. This Diagnosis-Related Group bundles related gynecologic procedural care and associated inpatient resources for Medicare beneficiaries. It matters for Medicare payment because presence of a Major Complication or Comorbidity or Complication or Comorbidity elevates relative resource use and reimbursement compared with cases without these diagnoses. Hospitals use the Diagnosis-Related Group assignment to determine base Medicare inpatient payments for these procedures.
National Payment Rates
Across commercial payers the observed rate range spans from about $370 up to $62K, with the widest spread between minimum and maximum seen in Anthem. Refer to the payer table and the accompanying chart below for payer-specific quartiles and distribution details. Payer labels shown include Blue Cross Blue Shield, Anthem, Cigna, and Aetna.
The CMS 2023 data are national Medicare fee-for-service inpatient payments published under the CMS Provider Utilization and Payment Data program. The table below shows average total payment, average submitted covered charges, average Medicare payment amount, and total discharges for DRG 744 in 2023. Values reflect national-level averages and case volumes for Medicare FFS beneficiaries.